Latest Breaking News On - Hugues dolgos - Page 3 : comparemela.com

SIMIS Srl Appoints Laurent Contaut as the New CEO of SIMIS, Part of NMS Group of Companies

SIMIS Srl Appoints Laurent Contaut as the New CEO of SIMIS, Part of NMS Group of Companies
bdtonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bdtonline.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesLaurent contautAsia pacificLife sciencesContract research organizationsChief executive officerNorth americaNerviano siteDecentralized servicesAdministrative supportHugues dolgosBusiness wire

Nerviano Medical Sciences Announces Licensing of Linker-Payload Technology to Solve Therapeutics to Develop and Commercialize Novel Antibody-Drug Conjugates

/PRNewswire/ Nerviano Medical Sciences S.r.l. (NMS), a clinical-stage biotechnology company member of NMS Group S.p.A. (NMS group), the largest cancer.

United statesSan diegoNorth carolinaDavid johnsonPrnewswire nerviano medical sciencesSurveyor capitala citadel companyMerck coAyurmaya capital management fundNerviano medical sciencesTherapeutics incSolve therapeuticsHugues dolgosChief executive officerMatrix capital managementDecheng capitalGeneral atlantic

Nerviano Medical Sciences Strengthens Executive Team to Maximize IDH1/IDH2 Inhibitor Asset

Nerviano Medical Sciences Strengthens Executive Team to Maximize IDH1/IDH2 Inhibitor Asset
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoLisa mahnkeHead of program managementProgram managementZiopharm oncologyHead of clinical development at bicycle therapeuticsLeadership teamMerck kgaMerck kgaaNerviano medical sciences incRoche groupUniversity of phoenixUniversity of arizonaNerviano medical sciencesNew business

Nerviano Medical Sciences S r l : Nerviano Medical Sciences Strengthens Executive Team to Maximize IDH1/IDH2 Inhibitor Asset

Terrence West, MBA, joins as New Business, Virtual CEO Nerviano Medical Sciences S.r.l., a part of NMS Group S.p.A. (NMS Group), focused on the discovery and early development of oncology drugs and

United statesSan franciscoKostenloser wertpapierhandelLisa mahnkeHead of program managementProgram managementZiopharm oncologyHead of clinical development at bicycle therapeuticsLeadership teamMerck kgaMerck kgaaNerviano medical sciences incRoche groupUniversity of phoenixUniversity of arizonaNerviano medical sciences

Servier and Celsius Therapeutics Announce Target Discovery Collaboration in Colorectal Cancer - Press Release

Servier and Celsius Therapeutics Announce Target Discovery Collaboration in Colorectal Cancer - Press Release
digitaljournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitaljournal.com Daily Mail and Mail on Sunday newspapers.

United kingdomKendall squareTariq kassumServier bioinnovationSonia marquesServier groupBusiness wireCelsius therapeuticsHugues dolgosஒன்றுபட்டது கிஂக்டம்கெஂடெல் சதுரம்சோனியா மார்க்ஸ்வணிக கம்பிசெல்சியஸ் சிகிச்சை